October 12th, 2024

Psilocybin Bests SSRI for Major Depression in First Long-Term Comparison

A study at the European College of Neuropsychopharmacology Congress found psilocybin may offer better long-term outcomes than escitalopram for major depressive disorder, emphasizing patient-reported benefits and holistic treatment approaches.

Read original articleLink Icon
SkepticismGratitudeCaution
Psilocybin Bests SSRI for Major Depression in First Long-Term Comparison

A recent study presented at the 37th European College of Neuropsychopharmacology Congress indicates that psilocybin may provide superior long-term outcomes for patients with moderate to severe major depressive disorder (MDD) compared to the selective serotonin reuptake inhibitor (SSRI) escitalopram. The research, which is the first long-term comparison of these treatments, involved 59 adults who received either psilocybin or escitalopram over a six-week period, followed by a six-month assessment. While both treatments showed similar reductions in depressive symptoms, psilocybin was associated with greater improvements in overall well-being, social functioning, and meaning in life. The study highlighted a disconnect between psychiatric assessments focused on negative symptoms and patient-reported outcomes emphasizing life meaning and social connections. Researchers noted that psilocybin therapy could represent a more holistic approach to treating depression. However, the study's limitations included the lack of control over subsequent treatments received by participants. Experts suggest that if psilocybin is approved for clinical use, it will require specialized training for providers. The findings contribute to the growing body of evidence supporting psilocybin as a viable treatment option for depression, alongside ongoing larger trials.

- Psilocybin shows better long-term outcomes than escitalopram for MDD.

- The study emphasizes the importance of patient-reported outcomes over traditional psychiatric assessments.

- Psilocybin therapy may offer a more holistic approach to treating depression.

- Limitations include uncontrolled follow-up treatments received by participants.

- Specialized training may be necessary for providers if psilocybin is approved for clinical use.

Related

Next-generation psychedelics: should new agents skip the trip?

Next-generation psychedelics: should new agents skip the trip?

Companies are investing in next-generation psychedelics to enhance mental health treatment, focusing on reducing psychoactive effects while maintaining therapeutic benefits. Despite expanding interest and investments, questions persist about efficacy and cost-effectiveness.

New study shows reactions in the brain in people who were given psilocybin

New study shows reactions in the brain in people who were given psilocybin

Researchers at Washington University studied psilocybin's impact on the brain using functional M.R.I. scans. Results in Nature showed significant changes in introspective brain areas. Psilocybin's effects lingered post-drug, hinting at mental health benefits beyond placebos.

A scientist took a psychedelic drug – and watched his own brain 'fall apart'

A scientist took a psychedelic drug – and watched his own brain 'fall apart'

Researchers studied psilocybin's impact on the brain, finding it disrupts specific networks related to space, time, and self-awareness. This disruption enhances brain plasticity, potentially aiding in treating conditions like addiction and depression.

A scientist took a psychedelic drug – and watched his own brain 'fall apart'

A scientist took a psychedelic drug – and watched his own brain 'fall apart'

Researchers studied psilocybin's effects on the brain, finding disruptions in key networks enhancing plasticity. This desynchronization may aid addiction, depression, and PTSD treatment, despite varied experiences and acknowledged risks. Valuable insights for psychiatric integration.

Magic Mushrooms May Have Shaped Our Consciousness

Magic Mushrooms May Have Shaped Our Consciousness

A review by the Miguel Lillo Foundation suggests psilocybin may have influenced human consciousness for millions of years, enhancing cognitive functions and cultural practices, with potential therapeutic applications today.

AI: What people are saying
The comments reflect a range of opinions and experiences regarding the use of psilocybin for treating major depressive disorder compared to traditional SSRIs.
  • Many commenters share personal anecdotes highlighting the positive effects of psilocybin on their mental health, often contrasting it with negative experiences from SSRIs.
  • Criticism of the study's methodology is prevalent, with concerns about small sample sizes, lack of proper blinding, and potential biases in self-reported outcomes.
  • Some commenters emphasize the need for caution and further research, noting the complexities of mental health treatment and the risks associated with psychedelics.
  • There is a call for a more holistic approach to mental health care, focusing on meaningful life improvements rather than just symptom reduction.
  • Concerns about the commercialization and regulation of psilocybin treatments are raised, with skepticism about the motivations behind pharmaceutical interests.
Link Icon 43 comments
By @thegrim33 - 4 months
The results are based on a grand total of 25 people in the psilocybin group and 21 people in the SSRI group. The sample size is pretty small.

The methodology is also kind of strange, the psilocybin group got a total of 20 hours of in-person therapy during their 'treatment' and 6 follow-up skype calls, whereas the SSRI didn't get anything other than the 6 month questionaire. Those 20 hours of personalized therapy while they were dosing had no effect on their psychology? Any change was all a result of the psilocybin and not the 20 hours of therapy?

They also measured results by a self-administered 16 question "quick inventory" depression survey. To enter the study they had to be officially diagnosed with major depression by a doctor, but the results of the study were based completely around a self-reported 16 question questionaire?

By @neom - 4 months
Psilocybin saved my life. I'm no longer suicidal, I'm no longer a practicing alcoholic, and outside of a few things here and there, I'm generally at peace with my life. I cannot express how grateful I am for psilocybin.
By @torginus - 4 months
I have a theory that the medical community has a somewhat antagonistic view on mind-affecting drugs that work and have genuine positive effects - it's that healthy and/or undiagnosed people will take said drugs willingly, as they provide their positive effects for healthy individuals, and they'll instantly get labeled as abusable drugs, whose consumption is tied to heavy criminal charges. This reputation and the accompanying legal red tape makes medical research into said compounds very difficult.

An ironclad rule for medically approved drugs is that no fun is allowed - approved drugs must not have any positive effects on mood or well-being or must come with such heavy side effects that no sane healthy person would willingly take them.

For some reason, the medical profession considers the enhancement of one's quality of life beyond some arbitrarily chosen 'healthy' baseline to be forbidden, and is in cahoots with the executive branch to gatekeep it at all costs.

By @cubefox - 4 months
Unfortunately it's hardly possible to do proper case control studies with psilocybin, since the psychedelic effects cause unblinding. The participants know whether they are in the treatment or control group.

> Normally the journey is quite inward, so patients do not require active support during the psychedelic experience [around 6 hours]. Sometimes they do require some hand-holding, or helping them to 'let go', or breathing exercises. The important part is the integration work that comes afterwards," Barba added. [...]

> However, [Rucker] noted, it is also possible that the results reflect biased reporting between groups. This is more likely here because studies involving psilocybin tend to attract those with positive preconceptions about psilocybin and negative preconceptions about conventional antidepressants

By @DiscourseFan - 4 months
Ok like most of you I’ve taken psychedelic drugs. I’ve had bad experiences sure, but I’m fine now.

The issue is that what people generally say, like, “oh sometimes you need to encounter your demons,” maybe that will be temporarily traumatizing—in general people recover from that. The real issues are…more complex. More complex than any diagnoses in the DSM can cover. The brain is very complicated, and everyone’s brain is a bit different, and we do not know, really, what goes on in there when you take a drug like Psilocybin. Sometimes something gets a little knocked out of place, and the system doesn’t fully recover.

The last time I took a very high dose of psychedelics I couldn’t think straight for a few weeks after. Thoughts came out of nowhere, I had no control over them; often the constant, unceasing flow of thought was distressing and uncomfortable. Thankfully I could still talk to people—talking made me better. I got plenty of sleep, cut out all drugs, even caffiene, got regular exercise and ate a very healthy diet: about a year and a half later I was back to my old habits. But it wasn’t an easy recovery, and certainly not one any psychiatrist could’ve treated adaquetely. But, now I know to be more careful in the future.

By @awestroke - 4 months
I wonder how much of an uphill battle it will be to get psilocybin approved for therapeutic use compared to synthetic psilocybin analogues that are being trialed right now. Psilocybin can't be patented and it's already scheduled as a narcotic everywhere.
By @anonymouse3112 - 4 months
Anecdotally: worked for me, would absolutely do it again.

People worry about various side-effects: I work extremely hard and know others who have done psychedelics and continue with b2b saas and similar.

That said, it’s serious stuff. I think it permanently increased the amount that I like music; other studies show longtitudinal changes to big-five personality traits. Proceed with caution.

By @debacle - 4 months
I have been taking seratonin precursors (5-HTP, a supplement) for about 4 months at a very low dosage (.3 of the "normal dose").

My chronic depression is mostly gone, but I have noticed an uptick in physiological signs of anxiety (though no mental signs).

But more importantly, my gut health is better than it has been in 12 years. I am eating more and losing weight. My energy levels have skyrocketed. My impulsiveness has catered so hard that I was worried my libido was impacted. My executive function issues and ADHD are greatly minimized.

All from a supplement. Utterly life changing.

By @state_less - 4 months
> "Psychiatrists really focus on negative symptoms of depression. So, if you are not sad anymore, if your sleep or appetite is not impaired, they think you're better. But if you look at what patients define as important, they say it's the degree in which their life is meaningful, in which they can connect with people around them, in which they can function in everyday life," Barba said.

A more wholistic approach to health care would be beneficial. For folks looking for more depth or purpose, Psilocybin seems to help reconnect people with a part of themselves they only dimly remember.

I often hear people talk about the risks of psychedelics, which are to be considered, but what’s the risk of doing nothing or withholding the best treatment?

By @Mistletoe - 4 months
It’s a neat study. I don’t know how you account for the intense placebo effect of a psychedelic experience for six hours though. We know that traditional antidepressants may work through this method already where you feel “different” and fix yourself. Trials with an active placebo often have results very similar to antidepressants.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172306/

I guess maybe it doesn’t even matter in the end as long as people feel better.

By @dillydogg - 4 months
I think a major criticism of how this study is designed is that it is not truly "blinded". I doubt many of the participants were unsure if they received psilocybin vs escitalopram.

That being said, there are a number of studies that suggest this is an effective treatment, so I hope this can become more available to those who need it. However, for treatment resistant depression (especially with a catatonia component), intranasal ketamine is very hard to beat. Only topped by ECT in my experience.

By @shadowtree - 4 months
Ah, but does it beat exercise, fresh air and sunlight?

https://www.mayoclinic.org/diseases-conditions/depression/in...

By @xterminator - 4 months
Psychedelics are nice and powerful - maybe too powerful. I don't trust the system to use them responsibly. I'd rather obtain and use them on my own than as part of some private - or governmental - initiative. There's no one to trust more than a good friend to be there for you when the ride gets bumpy, not some guy in a suit doing it for the money.
By @ValentinA23 - 4 months
https://en.wikipedia.org/wiki/Selective_serotonin_reuptake_i...

>Post-SSRI sexual dysfunction (PSSD)[62][63] refers to a set of symptoms reported by some people who have taken SSRIs or other serotonin reuptake-inhibiting (SRI) drugs, in which sexual dysfunction symptoms persist for at least three months[64][65][66] after ceasing to take the drug. The status of PSSD as a legitimate and distinct pathology is contentious; several researchers have proposed that it should be recognized as a separate phenomenon from more common SSRI side effects.[67]

>The reported symptoms of PSSD include reduced sexual desire or arousal, erectile dysfunction in males or loss of vaginal lubrication in females, difficulty having an orgasm or loss of pleasurable sensation associated with orgasm, and a reduction or loss of sensitivity in the genitals or other erogenous zones. Additional non-sexual symptoms are also commonly described, including emotional numbing, anhedonia, depersonalization or derealization, and cognitive impairment.[64][68] The duration of PSSD symptoms appears to vary among patients, with some cases resolving in months and others in years or decades;

https://www.pssdnetwork.org/

At least, the mushroom didn't steal my mojo

By @lumb63 - 4 months
Exercise also bests SSRIs. Having had multiple close family members and friends try various cocktails of SSRIs and other drugs for depression, bipolar disorder, and borderline personality disorder, and having to see the side effects they experience, and how many different dosings and combinations need to be tried before they find something that doesn’t make them worse, I would not recommend such medication to anyone with similar issues without trying other more conservative approaches first.
By @8b16380d - 4 months
Funny, psilocybin has been largely detrimental to the mental health of everyone I know.
By @modeless - 4 months
Bad headline. Psilocybin was not significantly different for depression symptoms. Also there was no control group. Confidence intervals were very large. Yet another unconvincing study with bad journalism.
By @cpucycling7 - 4 months
This has been common knowledge among mushroom friends for a long time now. But it's always nice when the mainstream population gets "something official" that helps them open up to knowledge that is otherwise being censored quite everywhere.

Also, SSRI can definitely kill your sex life - and by extension your relationship(s) as well. And not just short-term (physiological changes have been observed). SSRIs have never been the best option (except for pharmaceutical companies).

By @homakov - 4 months
Every psychodelic experience is unique & random, even if the title was the opposite and in their study SSRI turned out to be better doesn't mean it will be better for you.

From my personal experience, SSRI (zoloft) felt like a temporary coffee-like stimulant. Psilocybin (or easier to handle synthetic analog 4-aco-dmt) provided short-acting relief from depression and some new perspectives. But ketamine is truly a magic pill if done right. After glow is about a month, and the trip takes 2-3 hrs max. FDA-approved, see Spravato. I feel like at some point ketamine therapy at scale would make SSRIs obsolete, it's just better and faster.

By @photochemsyn - 4 months
Full research article:

https://www.thelancet.com/action/showPdf?pii=S2589-5370%2824...

Study design and methods:

> "All the patients provided written informed consent and after discontinuing any pre-trial antidepressants, enrollees received two oral doses of psilocybin (1 mg or 25 mg) with accompaniment from two experienced therapists for ∼6–8 h, separated by 3 weeks, as well as daily pills (escitalopram 10–20 mg or placebo capsules). Thirty patients were randomised to PT and 29 to ET."

> 'The PT condition consisted of two high-dose (25 mg) treatment sessions with the serotonergic psychedelic psilocybin, administered with support from two study therapists...and daily placebo capsules. The ET condition consisted of daily doses of the selective serotonin reuptake inhibitor (SSRI) escitalopram - 10 mg for three weeks followed by 20 mg for a further three weeks—as well as equivalent psychological support including dosing sessions with placebo-like doses of psilocybin (1 mg)."

This is an interesting way to address the placebo issue, giving a noticeable microdose of psilocybin (1 mg) versus the active dose (25 mg) for the non-control group.

Fundamentally I think psilocybin's main overall psychological effect is to push subconscious issues up into the mind's conscious processing space. Large doses can generate visual hallucinations related to those subconscious issues which can be unpleasant, even terrifying, for many people, so that's why caution is warranted. Extremely large doses cause complete dissociation from external sensory input, which is of course very dangerous for the unprepared individual in an uncontrolled situation - an experience unlikely for any herbivore to want to repeat, hence the evolutionary selection pressure for biosynthesis of such compounds by plants and fungi.

By @iluvcommunism - 4 months
It’ll be good to find positive effects in natural remedies like this. It is ironic we try to keep people safe from themselves but end up dolling out ineffective or destructive drugs instead. A case in point, opium being illegal, but a lab derivative 1k stronger fentanyl, legal and 300k killed globally over the last 10 years.
By @more_corn - 4 months
One big problem with SSRIs is that they cause a massive down-swing when you’re coming off of them and they take two weeks to start working. I guess that’s two problems. If they were otherwise comparable and lacked those two negatives (which it seems they do) it’d be worth exploring them. They should certainly be reclassified away from schedule 1 since they clearly have a medical use. I think it’s also clear they’re not addictive.
By @pessimizer - 4 months
From what I recall, SSRIs only show an effect greater than placebo in major depression, and that effect goes away if the placebo is active (i.e. the placebo makes you a little sick, so you can "feel it working.")

Great idea to compare a new trendy treatment with promise of potential financial windfalls to another treatment that barely works. If you kept feeding them cocaine under medical supervision, they'd probably report feeling slightly better, too. They're recreational drugs. People take them because they feel good. The most common symptom of depression is to take refuge in drug consumption.

By @sub7 - 4 months
I do LSD once a year with close friends and a beautiful view and it's fantastic at making me appreciate beauty in the world and feel like everything is in it's natural place.

Shrooms sadly do not agree with my digestive system.

By @el_nahual - 4 months
Will add a personal anecdote on my mental-health journey and the impact psylocibin has had on my life.

Bio:

- Late 30s.

- Long history of depression my entire life. "Melancholic" child. Bad drunk teenager. Suicidal in college (failed attempt).

- No drugs except alcohol until I was in my mid 20s.

I've been prone to major bouts of depression my entire life. I went to therapy multiple times a week for years and got on SSRI's towards the end of university as a response to a failed (but serious) suicide attempt.

SSRI's never did anything for me except make me feel like shit (and not be able to take one). Eventually I went off them and sort of got by, and I managed to stay safe by drinking no alcohol. Therapy twice a week was an utter waste of time and money.

Then, sort of on a whim, I grew some mushrooms at home with my then fiancée and we took them together. I was mid 20s and had no prior experience with any drug but alcohol. Not knowing what I was doing, we took a BIG dose. I had a trip that was fun at first and then became quite unenjoyable.

For the next twelve months I felt like myself again. The change was subtle but, over a long term, quite obvious.

After about 18 to 24 months, my depression came back. We took mushrooms again and the same thing happened. A year of well being in exhcange for 2 fun hours and 6 tough ones.

So about every two years I'll take a big (2-4g dry) dose of mushrooms and...it's like magic. I feel like myself again. I'm "back." Life is not happy, none of my problems go away, but I feel like I'm an agent in my own life as opposed to a spectator.

The well being lasts about a year or 18 months (less if I've been drinking alcohol). It's almost never as bad as when I was suicidal, but it still sucks. For me depression is like being a professional chef and one day your taste buds make everything taste like ash. Or a painter and one day you see colors less and less.

Last year I went into a VERY deep depression, so deep that I refused to take mushrooms until my wife basically forced me to. Same thing. The very next day I felt like "I was back."

Those things changed my life.

I've since had fun with other drugs maybe 5 times. Acid a couple times, molly a couple times. Cheap (wtf) fun for a half a day, but nothing like the impact mushrooms have on my mind.

I've had one bad trip while taking mushrooms recreationally. I don't understand who would take those things for fun, at night.

Strictly during the day, well-rested, with loved ones, and in nature!

I'm also convinced that the impact they have on me is purely chemical. It has nothing to do with "facing my demons" or "connecting with a higher spirit" or anything like that. I just get off my stupid rut.

"Neurons that fire together wire together" as they say, and when I'm depressed it's the stupid neurons that fire together. Mushrooms makes a whole different set fire, and fire hard, and that seems to be enough.

The deepeest lesson I've gotten while on shrooms is:

"I'm trying my best. Everything is actually fine."

Pretty good lesson.

By @chiefalchemist - 4 months
When this topic comes up on HN I'm always sure to mention the book:

"How to Change Your Mind" by Michael Pollan

There's also a Netflix doc series based on the book.

https://michaelpollan.com/books/how-to-change-your-mind/

By @Molitor5901 - 4 months
Very much related. Many people are getting shrooms through establishments selling it in the form of chocolate. However it is apparent that much of that is adulterated and synthetic.

https://news.ycombinator.com/item?id=41283493

By @newsclues - 4 months
Taking LSD every few months was the best antidepressant I’ve ever tried and I’ve tried a bunch
By @AI_beffr - 4 months
in 2020 i was very interested in psychedelics because of the breakthrough with PTSD and MDMA via MAPS. so i read pihkal and tihkal and i started reading a biochemistry textbook and generally took an intense interest in that area. and i went to oakland when i had the chance to be back in the bay area and i went to zide door and bought a small amount of psilocybin. at a bohemian friends house (it has since been cleaned out and sold, perhaps the last such house in the bay area at the time!) i took the little capsule in my palm and contemplated if i really wanted to take the risk. and i did. it was not a large enough dose to produce a psychoactive effect -- i think i had read that a psychoactive dose was not necessary to see benefits in mental health. there is one effect that i remember very clearly. it was when it got later into the night that i noticed something subtle but extremely strange. i felt awake or energized in some way. and i realized that my whole life, during the evening and late hours i would be sort of depressed and not feeling good. and so that was the first time that i felt lucid and energized after dusk. my whole life i had always known that i feel very depressed and agitated at dusk. but this experience really showed me how abnormal it was. later on i made a connection that is very oddly absent in medical circles that explains this. you know how when someone is having a deadly allergic reaction they are meant to use what is known as an "epi-pen?" thats because epinephrine, whats inside the pen, reduces inflammation. but what isnt mentioned or connected anywhere to anything is that when you go to sleep at night your body massively reduces the level of epinephrine that circulates in your blood so that you can sleep. inflammation therefore must increase. and inflammation is implicated in many psychiatric disorders including and perhaps most of all with depression.

one time much later i was in the hospital because i had a bad fever. maybe i was being kind of paranoid for going in. but as i was laying in the hospital bed my fever suddenly broke. and a wave of intense depression, unmistakable, washed over me. i thought this might be turning into an emergency but soon enough it passed as if nothing had happened. it was very useful to know about the connection between inflammation and depression during that little journey.

why is the connection between inflammation and various psychiatric diseases not taken seriously by the medical establishment? because its too complicated of a subsystem for a statistical study to tease it out. even if it were the sole cause of depression it still wouldnt lend itself to any study that is not exploring directly the biochemical mechanism. expect some breakthroughs in this area.

By @jdietrich - 4 months
Obligatory notes of caution:

The primary outcome of depression symptoms (QIDS-SR-16) was not significantly different between the groups. The sample size is small and unrepresentative of the real-world population of depression patients - the trial participants are very disproportionately male and university-educated. There are obvious and much-discussed issues with blinding in psychedelic trials.

These results point to a treatment that may be superior to treatment-as-usual for a minority of patients, but the results certainly aren't revolutionary. There is still the potential for significant risk in wider clinical populations who may have psychiatric comorbidities that would exclude them from trials like this, and in delivering psychedelic treatments in more normal clinical settings that are likely to be far less carefully controlled than a clinical trial.

By @ein0p - 4 months
I’m pretty sure getting repeatedly punched in the head would “best SSRIs” in a long term comparison too. Hasn’t the entire body of research that gave us SSRIs been exposed as fraud a couple of years ago?
By @black_puppydog - 4 months
Lol, I opened this in a tab in background and until I foregrounded the tab it reloaded every 2 seconds or so. I hate the modern web... :)
By @_iaoo - 4 months
What 2 decades of on & off therapies and meds couldn't fix, a single psilocybin trip fixed in 5 hours. That's all the proof I need.

Not even getting into the side-effects of SSRIs including PSSD, brain zaps, lethargy, and a whole lot more.

I just don't understand people who do this shit recreationally, as it was quite possibly the worst experience I had in my life.

By @EGreg - 4 months
Didnt a lot of studies finally come out by 2022 showing that SSRIs are not actually effective for most people, no more than a placebo? And the whole link between serotonin and depression was spurious…

2021: https://jamanetwork.com/journals/jamapsychiatry/fullarticle/...

2022: https://www.jwatch.org/na55225/2022/08/16/antidepressants-wo...

2023: https://www.nature.com/articles/s41380-022-01661-0

In any case, I believe that ADHD, Depression and many other “umbrella” psychiatric diagnoses are being overdiagnosed, much like “hysteria” was for hundreds of years (eg 1 in 4 middle-aged women is on antidepressants now, and the opioid epidemic in men was largely exacerbated by the pharma industry, as has the overdiagnosis of ADHD prescribing amphetamines to kids).

To be fair, the actual incidence of phychiatric conditions from ADHD to autism to depression has increased, as well as autoimmune disorders, diabetes etc. although not as much as the pharma industry wants us to believe. It could very well be the result of upstream changes in nutrition (eg wild increases in sugars like fructose across the board, antibiotic overuse on factory farms, buildup of microplastics everywhere etc.), and to a large degree society (including loneliness, dating, relationships, work, etc) and medicating them downstream (eg with amphetamines or opioids) is just a bandaid.

Late stage capitalism has had a direct role in exacerbating this. For example, the tech industry (which many on HN are involved in) has redefined dating, relationships, job searches, political discourse, and much more. All of these affect how people interact. A seminal book even back in 2001 was “Bowling Alone” by Robert Putnam, who noticed Americans aren’t attending communal activities like they used to. Corporations have co-opted many movements (like women’s lib) to make people work harder, neglect their kids, eat unhealthy food, become obese, develop diabetes, lose sleep, and now be part of the gig economy etc.

I like to show this Cadillac commercial from 2014 as a great example of the corporate brainwashing: https://www.youtube.com/watch?v=xNzXze5Yza8

By @jtrn - 4 months
This comment ignores the possible effectiveness of both psilocybin and SSRIs and focuses on the usefulness of the research itself. I actually believe that both have a role in psychiatry, but this study tells me nothing with regards to therapy.

Working as a clinical psychologist, who also reads a lot of research, this study is just another brick in the wall that I am banging my head against when it comes to doing actual evidence-based therapy. I actually read the entire paper and the pre-registration. The title on Medscape and the article are, to me, completely reading the research wrong, and just another example of the actual research design and findings living in a different universe than the press release and subsequent discussion.

Let me try to communicate why I feel this way by summarizing the research in my way, as opposed to the title: "Psilocybin Bests SSRI for Major Depression in First Long-Term Comparison."

Hers my take: Research finds no significant difference between psilocybin and SSRI in the primary outcome from pre-registration (self-reported depression on an emailed form), even when only administering SSRI for 6 weeks, where the maximum effect of SSRI is expected at 12 weeks. As such, this does not even qualify as standard treatment with SSRI. This is after excluding 90% of the applicants for the study. The effectiveness is primary supported by p-hacking, as seen by reporting additional measures not in the registered, where some of them favor psilocybin. And SSRI actually scores BETTER in the main outcome.

Now, someone might come along and call me cynical, mistaken, or worse. But having been through this with biofeedback, metacognitive therapy, light therapy, mindfulness therapy, and ketamine treatment already, I can clearly see the same pattern: lying by omission, p-hacking, not taking into account the "decline effect," borderline acceptable results. It all culminates in a big nothingburger, and any progress for my field remains stagnant. Based on the quality of this study, I am certain that if we just aggressively started treating depression with psilocybin, I just know that it wouldn't make much difference, because I have been through it before with the exact same numbers and effect sizes, just different treatment modalities.

Here is the best indication I found for SSRI: Resistant phobic anxiety (panic attacks that don't stop even after long exposure), and burnout-related depression (person worked normally their whole life but is suddenly just empty of energy and does not look forward to anything with joy). These are examples that very often make a big difference with SSRI, in conjunction with therapy.

Psilocybin seems to work best for existential depression and anxiety that is driven by pathological self-focus (not egotism, but inability to stop focusing on one's own inner states).

But these personal theories are just that, and the studies that keep getting funding are very seldom useful, at least for me, as I genuinely am trying my best to help my patients.

By @mrangle - 4 months
Serenity Now, Insanity Later
By @keepamovin - 4 months
But no patent, so this is "misinformation" haha
By @Grandeculio - 4 months
No shit.